Labetalol Hydrochloride
- Product NDC
- 70518-2903
- 11-digit product format
- 705182903
- Labeler code
- 70518
- Product ID
- 70518-2903_d7960f82-12bf-f8e9-e053-2995a90a6e91
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Labetalol Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA207863
- Marketing category
- ANDA
- Marketing start
- 2020-10-08
- Marketing end
- 0000-00-00
- Substance
- LABETALOL HYDROCHLORIDE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2903-0 | 70518290300 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-2903-0) | 2020-10-08 | 0000-00-00 | No | No | Current |